RSV Vaccines May Increase Risk of Rare Neurological Condition
By Meghan Redshaw Recently approved vaccines for respiratory syncytial virus (RSV) for older adults may be linked to a rare nervous system disorder that causes the body’s immune system to attack its own nerves. In a Feb. 29 meeting of the Advisory Committee on Immunization Practices, health officials presented data that appears to show a slightly elevated rate of Guillain-Barré syndrome…
More Stories
QUINT Self Reported Market Capitalization Achieves $1.17 Million (QUINT)
QUINT (QUINT) traded up 1% against the U.S. dollar during the 1-day period ending at 10:00 AM E.T. on December...
Terra Price Reaches $0.44 on Top Exchanges (LUNA)
Terra (LUNA) traded down 0.4% against the dollar during the 1 day period ending at 10:00 AM E.T. on December...
Axie Infinity (AXS) Reaches Self Reported Market Cap of $1.02 Billion
Axie Infinity (AXS) traded 1.7% higher against the US dollar during the one day period ending at 10:00 AM ET...
TerraClassicUSD (USTC) Price Hits $0.0204
TerraClassicUSD (USTC) traded down 0.8% against the US dollar during the 24 hour period ending at 10:00 AM Eastern on...
GENinCode (LON:GENI) Trading Up 2.9% – Should You Buy?
GENinCode Plc (LON:GENI – Get Free Report)’s stock price traded up 2.9% during trading on Thursday . The company traded...
Toray Industries, Inc. (OTCMKTS:TRYIY) Short Interest Update
Toray Industries, Inc. (OTCMKTS:TRYIY – Get Free Report) was the target of a large decline in short interest in the...